Optimizing allogeneic grafts in hematopoietic stem cell transplantation
1Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, People's Republic of China.
Stem Cells Translational Medicine
|November 1, 2021
Summary
Optimizing allogeneic grafts for hematopoietic stem cell transplantation (HSCT) improves outcomes by enhancing engraftment and immune recovery while minimizing graft-vs-host disease. Further research aims to identify specific cellular components for even better results.
Area of Science:
- Hematology
- Immunology
- Transplantation Science
Background:
- Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a critical treatment for hematological diseases.
- Graft composition significantly impacts allo-HSCT prognosis, engraftment, immune reconstitution, and the balance between graft-vs-leukemia (GVL) and graft-vs-host disease (GvHD).
Purpose of the Study:
- To introduce the concept of optimized grafts in allo-HSCT.
- To review recent advancements in graft optimization strategies and their impact on transplantation outcomes.
Main Methods:
- Review of existing literature on graft manipulation and sources for allo-HSCT.
- Analysis of strategies aimed at improving engraftment, immune reconstitution, GVL effect, and reducing GvHD.
Main Results:
- Current clinical practice involves optimized allogeneic grafts to enhance engraftment and immune recovery.
- Optimized grafts aim for rapid immune reconstruction and a potent GVL effect with minimized GvHD.
- Significant efforts have been dedicated to developing optimized grafts through various manipulation techniques and source selections.
Conclusions:
- There is no universal standard for optimized grafts in allo-HSCT.
- Future research directions include identifying specific cellular components responsible for allo-HSCT effects to further refine graft optimization.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
563
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
563
01:24Tissue Transplantation
587
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
587